Income Statement Wintest Corp.

Stocks

6721

JP3154370005

Semiconductor Equipment & Testing

Delayed Japan Exchange 22:30:00 2026-08-16 EDT			5-day change	1st Jan Change
70.00 ^JPY	-7.89%		-9.09%	-35.78%

03-30	Wintest Corp. Auditor Raises 'Going Concern' Doubt	CI
01-13	Wintest Corp. announced that it has received ¥12.11 million in funding from abc Co., Ltd.	CI

72bebd01205b.iyv58mVTLgCSODO-bOM6qT_qkASxwnlZ7gOK44_Jx_Y.02W7vg89djPGCQPqDdZY53um31DJhClrp3Ttitmxpo_jfM2wPBBgRvh5Bw

Published financial data: WINTEST CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	307M	210M	407M	417M	429M
Total Revenues	307M	210M	407M	417M	429M
Cost of Goods Sold, Total	290M	148M	256M	756M	920M
Gross Profit	17M	62M	151M	-339M	-491M
Selling General & Admin Expenses, Total	482M	508M	477M	517M	511M
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	266M	247M	232M	227M	216M
Other Operating Expenses, Total	748M	755M	709M	744M	727M
Operating Income	-731M	-693M	-558M	-1.08B	-1.22B
Interest Expense, Total	-	-4M	-5M	-11M	-4M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-	-4M	-5M	-11M	-4M
Currency Exchange Gains (Loss)	56M	11M	13M	-	-
Other Non Operating Income (Expenses)	7M	2M	-2M	0	2M
EBT, Excl. Unusual Items	-668M	-684M	-552M	-1.09B	-1.22B
Gain (Loss) On Sale Of Investments	41M	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	2M
Asset Writedown	-3M	-	-	-9M	-30M
Other Unusual Items	-	-	-	-	8M
EBT, Incl. Unusual Items	-630M	-684M	-552M	-1.1B	-1.24B
Income Tax Expense	-1M	2M	2M	2M	2M
Earnings From Continuing Operations	-629M	-686M	-554M	-1.1B	-1.24B
Net Income to Company	-629M	-686M	-554M	-1.1B	-1.24B
Net Income - (IS)	-629M	-686M	-554M	-1.1B	-1.24B
Net Income to Common Incl Extra Items	-629M	-686M	-554M	-1.1B	-1.24B
Net Income to Common Excl. Extra Items	-629M	-686M	-554M	-1.1B	-1.24B
Per Share Items
Net EPS - Basic	-19.04	-19.87	-13.84	-25.25	-23.44
Basic EPS - Continuing Operations	-19.04	-19.87	-13.84	-25.25	-23.44
Basic Weighted Average Shares Outstanding	33.04M	34.53M	40.03M	43.76M	52.99M
Net EPS - Diluted	-19.04	-19.87	-13.84	-25.25	-23.44
Diluted EPS - Continuing Operations	-19.04	-19.87	-13.84	-25.25	-23.44
Diluted Weighted Average Shares Outstanding	33.04M	34.53M	40.03M	43.76M	52.99M
Normalized Basic EPS	-12.64	-12.38	-8.62	-15.62	-14.39
Normalized Diluted EPS	-12.64	-12.38	-8.62	-15.62	-14.39
Supplemental Items
EBITDA	-	-	-	-	-1.21B
EBITA	-731M	-693M	-558M	-1.08B	-1.22B
EBIT	-731M	-693M	-558M	-1.08B	-1.22B
Effective Tax Rate - (Ratio)	0.16	-0.29	-0.36	-0.18	-0.16
Normalized Net Income	-418M	-428M	-345M	-684M	-762M
Supplemental Operating Expense Items
General and Administrative Expenses	62M	45M	42M	40M	44M
Research And Development Expense From Footnotes	266M	247M	232M	227M	216M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	219M	278M	361M	90M	82M
Total Cash And Short Term Investments	219M	278M	361M	90M	82M
Accounts Receivable, Total	36M	42M	108M	88M	213M
Other Receivables	45M	13M	5M	26M	25M
Total Receivables	81M	55M	113M	114M	238M
Inventory	1.48B	1.52B	1.46B	948M	545M
Other Current Assets, Total	87M	26M	18M	19M	26M
Total Current Assets	1.87B	1.88B	1.95B	1.17B	891M
Long-term Investments	25M	24M	24M	23M	27M
Other Intangibles, Total	-	-	-	-	-
Other Long-Term Assets, Total	1M	1M	-	1M	1M
Total Assets	1.9B	1.9B	1.97B	1.2B	919M
Liabilities
Accounts Payable, Total	82M	21M	12M	100M	221M
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	-	157M	-	100M	100M
Current Portion of Long-Term Debt	13M	32M	32M	32M	32M
Current Income Taxes Payable	50M	85M	66M	93M	81M
Other Current Liabilities	56M	78M	54M	51M	47M
Total Current Liabilities	201M	373M	164M	376M	481M
Long-Term Debt	96M	169M	136M	104M	72M
Long-Term Leases	-	-	-	7M	6M
Other Non Current Liabilities	10M	8M	9M	10M	16M
Total Liabilities	307M	550M	309M	497M	575M
Common Stock, Total	1B	1.21B	1.63B	1.67B	2.03B
Additional Paid In Capital	1.29B	1.5B	1.91B	1.96B	2.32B
Retained Earnings	-775M	-1.47B	-2.02B	-3.13B	-4.37B
Comprehensive Income and Other	78M	113M	147M	193M	370M
Total Common Equity	1.59B	1.35B	1.66B	698M	344M
Total Equity	1.59B	1.35B	1.66B	698M	344M
Total Liabilities And Equity	1.9B	1.9B	1.97B	1.2B	919M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	33.13M	37.03M	43.64M	52.6M	53.64M
ECS Total Common Shares Outstanding	33.04M	36.07M	43.64M	45.06M	53.64M
Book Value / Share	48.09	37.48	38.13	15.49	6.41
Tangible Book Value	1.59B	1.35B	1.66B	698M	344M
Tangible Book Value Per Share	48.09	37.48	38.13	15.49	6.41
Total Debt	109M	358M	168M	243M	210M
Net Debt	-110M	80M	-193M	153M	128M
Inventories - Raw Materials, Total	510M	506M	525M	316M	193M
Inventories - Work In Process, Total	813M	797M	813M	597M	293M
Inventories - Finished Goods, Total	159M	215M	118M	33M	57M
Inventories - Others	1M	-	1M	2M	2M
Full Time Employees	87	77	72	72	68
Order Backlog	692M	840M	768M	560M	494M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-630M	-683M	-552M	-1.1B	-1.24B
Depreciation & Amortization - CF	-	-	-	-	8M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	-	-	-	-	8M
(Gain) Loss From Sale Of Asset	3M	-	-	9M	30M
(Gain) Loss on Sale of Investments - (CF)	-41M	-	-	-	-
Other Operating Activities, Total	-20M	12M	-4M	-1M	-3M
Change In Accounts Receivable	464M	-6M	-66M	20M	-120M
Change In Inventories	-557M	5M	115M	336M	518M
Change In Accounts Payable	-22M	-77M	-16M	81M	94M
Change in Other Net Operating Assets	-53M	136M	-35M	-4M	-39M
Cash from Operations	-856M	-613M	-558M	-662M	-751M
Capital Expenditure	-	-	-	-1M	-1M
Divestitures	23M	-	-	-	-
Sale (Purchase) of Intangible assets	-2M	-	-	-	-29M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	3M	-	-	-
Cash from Investing	21M	3M	-	-1M	-30M
Short Term Debt Issued, Total	-	158M	-	100M	100M
Long-Term Debt Issued, Total	80M	120M	-	-	-
Total Debt Issued	80M	278M	-	100M	100M
Short Term Debt Repaid, Total	-	-	-159M	-	-100M
Long-Term Debt Repaid, Total	-7M	-29M	-32M	-32M	-32M
Total Debt Repaid	-7M	-29M	-191M	-32M	-132M
Issuance of Common Stock	-	421M	833M	104M	700M
Other Financing Activities, Total	-5M	-3M	-1M	-1M	-1M
Cash from Financing	68M	667M	641M	171M	667M
Foreign Exchange Rate Adjustments	58M	-	-	222M	106M
Miscellaneous Cash Flow Adjustments	3M	2M	-	-	1M
Net Change in Cash	-706M	59M	83M	-270M	-7M
Supplemental Items
Cash Interest Paid	-	3M	5M	11M	4M
Cash Income Tax Paid (Refund)	17M	-11M	2M	2M	2M
Levered Free Cash Flow	-686M	-388M	-393M	-65.75M	-409M
Unlevered Free Cash Flow	-686M	-385M	-390M	-58.88M	-406M
Change In Net Working Capital	227M	-48M	41M	-619M	-377M
Net Debt Issued / Repaid	73M	249M	-191M	68M	-32M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-21.22	-22.81	-18	-42.73	-72.02
Return on Total Capital	-23.57	-25.42	-19.69	-48.82	-101.84
Return On Equity %	-33.82	-46.65	-36.74	-93.56	-238.39
Return on Common Equity	-33.82	-46.65	-36.74	-93.56	-238.39
Margin Analysis
Gross Profit Margin %	5.54	29.52	37.1	-81.29	-114.45
SG&A Margin	157	241.9	117.2	123.98	119.11
EBITDA Margin %	-	-	-	-	-282.05
EBITA Margin %	-238.11	-330	-137.1	-259.71	-283.92
EBIT Margin %	-238.11	-330	-137.1	-259.71	-283.92
Income From Continuing Operations Margin %	-204.89	-326.67	-136.12	-264.99	-289.51
Net Income Margin %	-204.89	-326.67	-136.12	-264.99	-289.51
Net Avail. For Common Margin %	-204.89	-326.67	-136.12	-264.99	-289.51
Normalized Net Income Margin	-135.99	-203.57	-84.77	-163.97	-177.74
Levered Free Cash Flow Margin	-223.41	-184.58	-96.53	-15.77	-95.28
Unlevered Free Cash Flow Margin	-223.41	-183.39	-95.76	-14.12	-94.7
Asset Turnover
Asset Turnover	0.14	0.11	0.21	0.26	0.41
Receivables Turnover (Average Receivables)	1.13	5.38	5.43	4.26	2.85
Inventory Turnover (Average Inventory)	0.25	0.1	0.17	0.63	1.23
Short Term Liquidity
Current Ratio	9.3	5.03	11.88	3.11	1.85
Quick Ratio	1.49	0.89	2.89	0.54	0.67
Operating Cash Flow to Current Liabilities	-4.26	-1.64	-3.4	-1.76	-1.56
Days Sales Outstanding (Average Receivables)	322.79	67.79	67.26	86.01	128.05
Days Outstanding Inventory (Average Inventory)	1.47K	3.7K	2.12K	582.16	296.17
Average Days Payable Outstanding	33.98	102.72	30.88	82.98	113.31
Cash Conversion Cycle (Average Days)	1.76K	3.67K	2.16K	585.2	310.9
Long Term Solvency
Total Debt/Equity	6.86	26.48	10.1	34.81	61.05
Total Debt / Total Capital	6.42	20.94	9.17	25.82	37.91
LT Debt/Equity	6.04	12.5	8.17	15.9	22.67
Long-Term Debt / Total Capital	5.65	9.88	7.42	11.8	14.08
Total Liabilities / Total Assets	16.19	28.92	15.66	41.59	62.57
EBIT / Interest Expense	-	-173.25	-111.6	-98.45	-304.5
EBITDA / Interest Expense	-	-	-	-	-302.5
(EBITDA - Capex) / Interest Expense	-	-	-	-	-302.75
Total Debt / EBITDA	-	-	-	-	-0.17
Net Debt / EBITDA	-	-	-	-	-0.11
Total Debt / (EBITDA - Capex)	-	-	-	-	-0.17
Net Debt / (EBITDA - Capex)	-	-	-	-	-0.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-79.22	-31.6	93.81	2.46	2.88
Gross Profit, 1 Yr. Growth %	-97.02	264.71	143.55	-324.5	44.84
EBITDA, 1 Yr. Growth %	-	-	-	-	-
EBITA, 1 Yr. Growth %	238.95	-5.2	-19.48	94.09	12.47
EBIT, 1 Yr. Growth %	238.95	-5.2	-19.48	94.09	12.47
Earnings From Cont. Operations, 1 Yr. Growth %	137.06	9.06	-19.24	99.46	12.4
Net Income, 1 Yr. Growth %	137.06	9.06	-19.24	99.46	12.4
Normalized Net Income, 1 Yr. Growth %	229.06	2.4	-19.3	98.19	11.52
Diluted EPS Before Extra, 1 Yr. Growth %	136.94	4.35	-30.33	82.45	-7.17
Accounts Receivable, 1 Yr. Growth %	-92.9	16.67	157.14	-18.52	142.05
Inventory, 1 Yr. Growth %	72.44	2.36	-4.02	-34.93	-42.51
Total Assets, 1 Yr. Growth %	-21.36	0.32	3.73	-39.43	-23.1
Tangible Book Value, 1 Yr. Growth %	-25.4	-14.92	23.08	-58.05	-50.72
Common Equity, 1 Yr. Growth %	-25.43	-14.92	23.08	-58.05	-50.72
Cash From Operations, 1 Yr. Growth %	-7.12	-28.39	-8.97	18.64	13.44
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	0
Levered Free Cash Flow, 1 Yr. Growth %	-	-43.48	1.35	-83.26	521.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-43.85	1.2	-84.89	590.02
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-62.3	15.14	40.92	2.67
Gross Profit, 2 Yr. CAGR %	-	-67.01	198.03	133.83	80.32
EBITA, 2 Yr. CAGR %	-	79.26	-12.63	25.01	47.74
EBIT, 2 Yr. CAGR %	-	79.26	-12.63	25.01	47.74
Earnings From Cont. Operations, 2 Yr. CAGR %	-	60.79	-6.15	26.92	49.73
Net Income, 2 Yr. CAGR %	-	60.79	-6.15	26.92	49.73
Normalized Net Income, 2 Yr. CAGR %	-	83.56	-9.1	26.47	48.67
Diluted EPS Before Extra, 2 Yr. CAGR %	-	57.24	-14.74	12.74	30.14
Accounts Receivable, 2 Yr. CAGR %	-	-71.22	73.21	44.75	40.44
Inventory, 2 Yr. CAGR %	-	32.86	-0.88	-20.97	-38.84
Total Assets, 2 Yr. CAGR %	-	-11.18	2.01	-20.74	-31.75
Tangible Book Value, 2 Yr. CAGR %	-	-20.33	2.33	-28.15	-54.53
Common Equity, 2 Yr. CAGR %	-	-20.35	2.33	-28.15	-54.53
Cash From Operations, 2 Yr. CAGR %	-	-18.44	-19.26	3.92	16.01
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-24.32	-58.81	2
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-24.62	-60.9	2.09
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-34.93	10.75	26.89
Gross Profit, 3 Yr. CAGR %	-	-	-35.76	171.18	99.33
EBITA, 3 Yr. CAGR %	-	-	37.28	14	20.68
EBIT, 3 Yr. CAGR %	-	-	37.28	14	20.68
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	27.81	20.66	21.88
Net Income, 3 Yr. CAGR %	-	-	27.81	20.66	21.88
Normalized Net Income, 3 Yr. CAGR %	-	-	39.58	17.87	21.27
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	19.87	9.87	5.67
Accounts Receivable, 3 Yr. CAGR %	-	-	-40.28	34.71	71.81
Inventory, 3 Yr. CAGR %	-	-	19.21	-13.86	-28.93
Total Assets, 3 Yr. CAGR %	-	-	-6.46	-14.26	-21.53
Tangible Book Value, 3 Yr. CAGR %	-	-	-7.9	-23.98	-36.63
Common Equity, 3 Yr. CAGR %	-	-	-7.91	-23.98	-36.63
Cash From Operations, 3 Yr. CAGR %	-	-	-15.4	-8.21	7
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-54.23	1.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-55.89	1.8
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-21.91
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-2.93
EBITA, 5 Yr. CAGR %	-	-	-	-	41.38
EBIT, 5 Yr. CAGR %	-	-	-	-	41.38
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	36.17
Net Income, 5 Yr. CAGR %	-	-	-	-	36.17
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	43.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	23.88
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-15.92
Inventory, 5 Yr. CAGR %	-	-	-	-	-8.72
Total Assets, 5 Yr. CAGR %	-	-	-	-	-17.54
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-30.56
Common Equity, 5 Yr. CAGR %	-	-	-	-	-30.56
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-4.01
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-54.34